14-23321471-TGGC-T

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM1BS1_Supporting

The NM_004643.4(PABPN1):​c.21_23delGGC​(p.Ala8del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000651 in 1,152,136 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00026 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00071 ( 0 hom. )

Consequence

PABPN1
NM_004643.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.81
Variant links:
Genes affected
PABPN1 (HGNC:8565): (poly(A) binding protein nuclear 1) This gene encodes an abundant nuclear protein that binds with high affinity to nascent poly(A) tails. The protein is required for progressive and efficient polymerization of poly(A) tails at the 3' ends of eukaryotic transcripts and controls the size of the poly(A) tail to about 250 nt. At steady-state, this protein is localized in the nucleus whereas a different poly(A) binding protein is localized in the cytoplasm. This gene contains a GCG trinucleotide repeat at the 5' end of the coding region, and expansion of this repeat from the normal 6 copies to 8-13 copies leads to autosomal dominant oculopharyngeal muscular dystrophy (OPMD) disease. Related pseudogenes have been identified on chromosomes 19 and X. Read-through transcription also exists between this gene and the neighboring upstream BCL2-like 2 (BCL2L2) gene. [provided by RefSeq, Dec 2010]
BCL2L2-PABPN1 (HGNC:42959): (BCL2L2-PABPN1 readthrough) This locus represents naturally occurring read-through transcription between the neighboring BCL2L2 (BCL2-like 2) and PABPN1 (poly(A) binding protein, nuclear 1) genes on chromosome 14. The read-through transcript encodes a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM1
In a region_of_interest Disordered (size 114) in uniprot entity PABP2_HUMAN there are 18 pathogenic changes around while only 0 benign (100%) in NM_004643.4
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.00071 (711/1001398) while in subpopulation EAS AF= 0.00229 (40/17466). AF 95% confidence interval is 0.00173. There are 0 homozygotes in gnomad4_exome. There are 350 alleles in male gnomad4_exome subpopulation. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PABPN1NM_004643.4 linkc.21_23delGGC p.Ala8del disruptive_inframe_deletion 1/7 ENST00000216727.9 NP_004634.1 Q86U42-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PABPN1ENST00000216727.9 linkc.21_23delGGC p.Ala8del disruptive_inframe_deletion 1/71 NM_004643.4 ENSP00000216727.4 Q86U42-1
BCL2L2-PABPN1ENST00000678502.1 linkc.529-691_529-689delGGC intron_variant ENSP00000503309.1 A0A7I2V383

Frequencies

GnomAD3 genomes
AF:
0.000259
AC:
39
AN:
150628
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000486
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000198
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.000489
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00120
AC:
9
AN:
7496
Hom.:
0
AF XY:
0.00126
AC XY:
5
AN XY:
3956
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.0152
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00153
Gnomad NFE exome
AF:
0.000781
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000710
AC:
711
AN:
1001398
Hom.:
0
AF XY:
0.000738
AC XY:
350
AN XY:
474352
show subpopulations
Gnomad4 AFR exome
AF:
0.000553
Gnomad4 AMR exome
AF:
0.00175
Gnomad4 ASJ exome
AF:
0.000475
Gnomad4 EAS exome
AF:
0.00229
Gnomad4 SAS exome
AF:
0.000212
Gnomad4 FIN exome
AF:
0.00213
Gnomad4 NFE exome
AF:
0.000652
Gnomad4 OTH exome
AF:
0.000932
GnomAD4 genome
AF:
0.000259
AC:
39
AN:
150738
Hom.:
1
Cov.:
32
AF XY:
0.000149
AC XY:
11
AN XY:
73640
show subpopulations
Gnomad4 AFR
AF:
0.0000484
Gnomad4 AMR
AF:
0.000198
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000489
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Oculopharyngeal muscular dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvitySep 20, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs193922941; hg19: chr14-23790680; API